Calreticulin mediates nerve growth factor-induced neuronal differentiation

Journal of Molecular Neuroscience

Volumn 47, Issue 3, 2012, Pages 571-581

  Shih, Yu Yin ^a,b   Nakagawara, Akira ^c   Lee, Hsinyu ^b   Juan, Hsueh Fen ^b   Jeng, Yung Ming ^d   Lin, Dong Tsamn ^d   Yang, Yung Li ^d   Tsay, Yeou Guang ^e   Huang, Min Chuan ^f   Pan, Chien Yuan ^b   Hsu, Wen Ming ^b,d   Liao, Yung Feng ^a,b  

^a INSTITUTE OF CELLULAR AND ORGANISMIC BIOLOGY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^e NATIONAL YANG MING UNIVERSITY   (Taiwan)

^f NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Calreticulin; GAP43; Nerve growth factor; Neuroblastoma; Neuronal differentiation; TrkA

Indexed keywords

ANTINEOPLASTIC AGENT; CALCIUM ION; CALRETICULIN; MITOGEN ACTIVATED PROTEIN KINASE; NERVE GROWTH FACTOR; PROTEIN TYROSINE KINASE A;

ANIMAL CELL; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CELL STRAIN; CELL VIABILITY; CLINICAL TRIAL; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; MAJOR CLINICAL STUDY; MEDIATOR; MOLECULE; MULTIMODALITY CANCER THERAPY; NERVE CELL DIFFERENTIATION; NEUROBLASTOMA; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; SURVIVAL RATE; WESTERN BLOTTING;

ANIMALS; CALRETICULIN; CELL DIFFERENTIATION; NERVE GROWTH FACTOR; NEURONS; PC12 CELLS; RATS; RECEPTOR, TRKA; UP-REGULATION;

EID: 84863868295     PISSN: 08958696     EISSN: 15591166     Source Type: Journal    
DOI: 10.1007/s12031-011-9683-3     Document Type: Article

References (27)

1. Brodeur GM (2003) Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer 3(3):203-216
2. Brodeur GM, Minturn JE, Ho R, Simpson AM, Iyer R, Varela CR, Light JE, Kolla V, Evans AE (2009) Trk receptor expression and inhibition in neuroblastomas. Clin Cancer Res 15(10):3244-3250
3. Chang HH, Lee H, Hu MK, Tsao PN, Juan HF, Huang MC, Shih YY, Wang BJ, Jeng YM, Chang CL, Huang SF, Tsay YG, Hsieh FJ, Lin KH, Hsu WM, Liao YF (2010) Notch1 expression predicts an unfavorable prognosis and serves as a therapeutic target of patients with neuroblastoma. Clin Cancer Res 16(17):4411-4420
4. Chao MV (2003) Neurotrophins and their receptors: a convergence point for many signalling pathways. Nat Rev Neurosci 4(4):299-309
5. Cohn SL, Pearson AD, London WB, Monclair T, Ambros PF, Brodeur GM, Faldum A, Hero B, Iehara T, Machin D, Mosseri V, Simon T, Garaventa A, Castel V, Matthay KK (2009) The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report. J Clin Oncol 27(2):289-297
6. Cowley S, Paterson H, Kemp P, Marshall CJ (1994) Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell 77(6):841-852 (Pubitemid 24187682)
7. De Bernardi MA, Rabins SJ, Colangelo AM, Brooker G, Mocchetti I (1996) TrkA mediates the nerve growth factor-induced intracellular calcium accumulation. J Biol Chem 271(11):6092-6098 (Pubitemid 26095413)
8. Fagan AM, Zhang H, Landis S, Smeyne RJ, Silos-Santiago I, Barbacid M (1996) TrkA, but not TrkC, receptors are essential for survival of sympathetic neurons in vivo. J Neurosci 16(19):6208-6218 (Pubitemid 26313995)
9. Gelebart P, Opas M, Michalak M (2005) Calreticulin, a Ca2+-binding chaperone of the endoplasmic reticulum. Int J Biochem Cell Biol 37(2):260-266 (Pubitemid 39330186)
10. Guo L, Nakamura K, Lynch J, Opas M, Olson EN, Agellon LB, Michalak M (2002) Cardiac-specific expression of calcineurin reverses embryonic lethality in calreticulin-deficient mouse. J Biol Chem 277(52):50776-50779 (Pubitemid 36042241)
11. Hsu WM, Hsieh FJ, Jeng YM, Kuo ML, Chen CN, Lai DM, Hsieh LJ, Wang BT, Tsao PN, Lee H, Lin MT, Lai HS, Chen WJ (2005) Calreticulin expression in neuroblastoma - a novel independent prognostic factor. Ann Oncol 16(2):314-321 (Pubitemid 40309316)
12. Hsu WM, Lee H, Juan HF, Shih YY, Wang BJ, Pan CY, Jeng YM, Chang HH, Lu MY, Lin KH, Lai HS, Chen WJ, Tsay YG, Liao YF, Hsieh FJ (2008) Identification of GRP75 as an independent favorable prognostic marker of neuroblastoma by a proteomics analysis. Clin Cancer Res 14(19):6237-6245
13. Johnson S, Michalak M, Opas M, Eggleton P (2001) The ins and outs of calreticulin: from the ER lumen to the extracellular space. Trends Cell Biol 11(3):122-129 (Pubitemid 32289442)
14. Mesaeli N, Nakamura K, Zvaritch E, Dickie P, Dziak E, Krause KH, Opas M, MacLennan DH, Michalak M (1999) Calreticulin is essential for cardiac development. J Cell Biol 144(5):857-868 (Pubitemid 29238963)
15. Michalak M, Corbett EF, Mesaeli N, Nakamura K, Opas M (1999) Calreticulin: one protein, one gene, many functions. Biochem J 344(Pt 2):281-292 (Pubitemid 30011581)
16. Nakagawara A (2004) Neural crest development and neuroblastoma: the genetic and biological link. Prog Brain Res 146:233-242
17. Nakagawara A, Ohira M (2004) Comprehensive genomics linking between neural development and cancer: neuroblastoma as a model. Cancer Lett 204(2):213-224 (Pubitemid 38167724)
18. Nakagawara A, Arima-Nakagawara M, Scavarda NJ, Azar CG, Cantor AB, Brodeur GM (1993) Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma. N Engl J Med 328(12):847-854 (Pubitemid 23084339)
19. Pang L, Sawada T, Decker SJ, Saltiel AR (1995) Inhibition of MAP kinase kinase blocks the differentiation of PC-12 cells induced by nerve growth factor. J Biol Chem 270(23):13585-13588
20. Peterson JR, Ora A, Van PN, Helenius A (1995) Transient, lectin-like association of calreticulin with folding intermediates of cellular and viral glycoproteins. Mol Biol Cell 6(9):1173-1184
21. Rauch F, Prud'homme J, Arabian A, Dedhar S, St-Arnaud R (2000) Heart, brain, and body wall defects in mice lacking calreticulin. Exp Cell Res 256(1):105-111 (Pubitemid 30211172)
22. Shimada H (2003) The International Neuroblastoma Pathology Classification. Pathologica 95(5):240-241
23. Shimada H, Ambros IM, Dehner LP, Hata J, Joshi VV, Roald B (1999a) Terminology and morphologic criteria of neuroblastic tumors: recommendations by the International Neuroblastoma Pathology Committee. Cancer 86(2):349-363 (Pubitemid 29327593)
24. Shimada H, Ambros IM, Dehner LP, Hata J, Joshi VV, Roald B, Stram DO, Gerbing RB, Lukens JN, Matthay KK, Castleberry RP (1999b) The International Neuroblastoma Pathology Classification (the Shimada system). Cancer 86(2):364-372 (Pubitemid 29327594)
25. Tsien RY (1980) New calcium indicators and buffers with high selectivity against magnesium and protons: design, synthesis, and properties of prototype structures. Biochemistry 19(11):2396-2404
26. Tung YT, Hsu WM, Wang BJ, Wu SY, Yen CT, Hu MK, Liao YF (2008) Sodium selenite inhibits gamma-secretase activity through activation of ERK. Neurosci Lett 440(1):38-43
27. Van Hooff CO, Holthuis JC, Oestreicher AB, Boonstra J, De Graan PN, Gispen WH (1989) Nerve growth factor-induced changes in the intracellular localization of the protein kinase C substrate B-50 in pheochromocytoma PC12 cells. J Cell Biol 108(3):1115-1125 (Pubitemid 19083755)